The balloon introducer system market size has grown rapidly in recent years. It will grow from $3.27 billion in 2025 to $3.6 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to limited availability of advanced balloon introducers, reliance on conventional normal balloons, increasing prevalence of coronary artery diseases, growing hospital interventional capabilities, adoption of stent graft procedures.
The balloon introducer system market size is expected to see strong growth in the next few years. It will grow to $5.23 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to development of cutting and scoring balloon introducers, expansion of drug-coated balloon usage, rising neurovascular intervention procedures, increasing ambulatory surgical centers adoption, integration of smart and automated delivery systems. Major trends in the forecast period include rising adoption of drug-coated balloon technologies, expansion of minimally invasive cardiovascular procedures, growing preference for rapid exchange and over-the-wire systems, increasing awareness of peripheral and neurovascular disease treatments, focus on catheterization laboratory efficiency and workflow optimization.
The increase in cardiovascular diseases is expected to propel the growth of the balloon introducer system market going forward. Cardiovascular diseases include conditions that affect the heart and blood vessels, such as heart attacks, strokes, and hypertension. The prevalence of cardiovascular diseases is rising due to increasing obesity and diabetes rates globally, combined with the widespread adoption of sedentary lifestyles and unhealthy dietary habits. Balloon introducer systems support minimally invasive procedures used to open blocked blood vessels, improving blood circulation in the treatment of cardiovascular diseases. For instance, in October 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, it was reported that in 2023, an estimated 57,100 adults aged 25 years and above experienced acute coronary events, averaging approximately 156 cases per day. Therefore, the increasing incidence of cardiovascular diseases is driving the growth of the balloon introducer system market.
Leading companies operating in the balloon introducer system market are focusing on advancing evidence-based product innovation and initiating large-scale clinical programs to validate performance in real-world settings, as demonstrated by Cordis’ SELUTION Global Coronary Registry. For example, in May 2025, Cordis Corporation, a US-based medical technology company, announced the launch of its SELUTION Global Coronary Registry, a major initiative designed to assess real-world outcomes of the SELUTION SLR Drug-Eluting Balloon in up to 10,000 patients globally. This five-year registry builds upon existing pre-clinical studies, proof-of-concept trials, and ongoing Level-1 randomized studies. Supported by a global steering committee of interventional cardiologists, the program aims to expand clinical understanding of drug-eluting balloon use in contemporary percutaneous coronary intervention practice and reinforce evidence-based innovation.
In October 2023, Cordis Corporation, a US-based medical company, acquired M.A. Med Alliance SA for $1.135 billion. Through this acquisition, Cordis intends to strengthen its market leadership in drug-eluting balloon technology by integrating SELUTION SLR technology, improving treatments for coronary and peripheral artery disease, and targeting access to nearly two million patients globally by 2027. MedAlliance is a Switzerland-based medical technology company focused on advanced drug-eluting balloons and balloon introducer systems for interventional cardiology and endovascular procedures.
Major companies operating in the balloon introducer system market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Cook Medical Inc., Teleflex Incorporated, BIOTRONIK SE & Co. KG, Merit Medical Systems Inc., MicroPort Scientific Corporation, Blue Sail Medical Co. Ltd., Asahi Intecc Co. Ltd., Japan Lifeline Co. Ltd., AngioDynamics Inc., OrbusNeich Medical, Biosensors International Group Ltd., Alvimedica Medical Technologies, Hexacath, Cardionovum GmbH, Concept Medical Inc, Endocor GmbH.
North America was the largest region in the balloon introducer system market in 2025. The regions covered in the balloon introducer system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the balloon introducer system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the balloon introducer system market by increasing the cost of imported medical devices and components, including drug-coated balloons and stent graft introducers. Segments such as cutting and scoring balloons and rapid exchange systems are most impacted, particularly in regions like Asia-Pacific and Europe where imports are significant. This has resulted in higher procedural costs and supply chain adjustments. On the positive side, tariffs have encouraged local manufacturing initiatives, promoted innovation in device design, and strengthened domestic production capabilities.
The balloon introducer system market research report is one of a series of new reports that provides balloon introducer system market statistics, including balloon introducer system industry global market size, regional shares, competitors with a balloon introducer system market share, detailed balloon introducer system market segments, market trends and opportunities, and any further data you may need to thrive in the balloon introducer system industry. This balloon introducer system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A balloon introducer system is a medical device used in interventional procedures to help insert a balloon catheter into a patient’s vascular system. It is commonly used during angioplasty to widen narrowed or blocked arteries by guiding the balloon catheter into position.
The main product types in the balloon introducer system include normal balloons, cutting and scoring balloons, drug-coated balloons, and stencil balloon introducers. Normal balloons are conventional devices used during angioplasty procedures to expand narrowed or obstructed arteries. These products incorporate technologies such as rapid exchange, over-the-wire, and fixed-wire balloon catheter systems, making them suitable for applications including coronary artery disease, peripheral artery disease, and neurological disorders. They serve end users such as hospitals, ambulatory surgical centers, and catheterization laboratories.
The balloon introducer system market consists of sales of balloon introducer sheaths, balloon dilators, hemostatic valves, and guiding catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The balloon introducer system market size is expected to see strong growth in the next few years. It will grow to $5.23 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to development of cutting and scoring balloon introducers, expansion of drug-coated balloon usage, rising neurovascular intervention procedures, increasing ambulatory surgical centers adoption, integration of smart and automated delivery systems. Major trends in the forecast period include rising adoption of drug-coated balloon technologies, expansion of minimally invasive cardiovascular procedures, growing preference for rapid exchange and over-the-wire systems, increasing awareness of peripheral and neurovascular disease treatments, focus on catheterization laboratory efficiency and workflow optimization.
The increase in cardiovascular diseases is expected to propel the growth of the balloon introducer system market going forward. Cardiovascular diseases include conditions that affect the heart and blood vessels, such as heart attacks, strokes, and hypertension. The prevalence of cardiovascular diseases is rising due to increasing obesity and diabetes rates globally, combined with the widespread adoption of sedentary lifestyles and unhealthy dietary habits. Balloon introducer systems support minimally invasive procedures used to open blocked blood vessels, improving blood circulation in the treatment of cardiovascular diseases. For instance, in October 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, it was reported that in 2023, an estimated 57,100 adults aged 25 years and above experienced acute coronary events, averaging approximately 156 cases per day. Therefore, the increasing incidence of cardiovascular diseases is driving the growth of the balloon introducer system market.
Leading companies operating in the balloon introducer system market are focusing on advancing evidence-based product innovation and initiating large-scale clinical programs to validate performance in real-world settings, as demonstrated by Cordis’ SELUTION Global Coronary Registry. For example, in May 2025, Cordis Corporation, a US-based medical technology company, announced the launch of its SELUTION Global Coronary Registry, a major initiative designed to assess real-world outcomes of the SELUTION SLR Drug-Eluting Balloon in up to 10,000 patients globally. This five-year registry builds upon existing pre-clinical studies, proof-of-concept trials, and ongoing Level-1 randomized studies. Supported by a global steering committee of interventional cardiologists, the program aims to expand clinical understanding of drug-eluting balloon use in contemporary percutaneous coronary intervention practice and reinforce evidence-based innovation.
In October 2023, Cordis Corporation, a US-based medical company, acquired M.A. Med Alliance SA for $1.135 billion. Through this acquisition, Cordis intends to strengthen its market leadership in drug-eluting balloon technology by integrating SELUTION SLR technology, improving treatments for coronary and peripheral artery disease, and targeting access to nearly two million patients globally by 2027. MedAlliance is a Switzerland-based medical technology company focused on advanced drug-eluting balloons and balloon introducer systems for interventional cardiology and endovascular procedures.
Major companies operating in the balloon introducer system market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Cook Medical Inc., Teleflex Incorporated, BIOTRONIK SE & Co. KG, Merit Medical Systems Inc., MicroPort Scientific Corporation, Blue Sail Medical Co. Ltd., Asahi Intecc Co. Ltd., Japan Lifeline Co. Ltd., AngioDynamics Inc., OrbusNeich Medical, Biosensors International Group Ltd., Alvimedica Medical Technologies, Hexacath, Cardionovum GmbH, Concept Medical Inc, Endocor GmbH.
North America was the largest region in the balloon introducer system market in 2025. The regions covered in the balloon introducer system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the balloon introducer system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the balloon introducer system market by increasing the cost of imported medical devices and components, including drug-coated balloons and stent graft introducers. Segments such as cutting and scoring balloons and rapid exchange systems are most impacted, particularly in regions like Asia-Pacific and Europe where imports are significant. This has resulted in higher procedural costs and supply chain adjustments. On the positive side, tariffs have encouraged local manufacturing initiatives, promoted innovation in device design, and strengthened domestic production capabilities.
The balloon introducer system market research report is one of a series of new reports that provides balloon introducer system market statistics, including balloon introducer system industry global market size, regional shares, competitors with a balloon introducer system market share, detailed balloon introducer system market segments, market trends and opportunities, and any further data you may need to thrive in the balloon introducer system industry. This balloon introducer system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A balloon introducer system is a medical device used in interventional procedures to help insert a balloon catheter into a patient’s vascular system. It is commonly used during angioplasty to widen narrowed or blocked arteries by guiding the balloon catheter into position.
The main product types in the balloon introducer system include normal balloons, cutting and scoring balloons, drug-coated balloons, and stencil balloon introducers. Normal balloons are conventional devices used during angioplasty procedures to expand narrowed or obstructed arteries. These products incorporate technologies such as rapid exchange, over-the-wire, and fixed-wire balloon catheter systems, making them suitable for applications including coronary artery disease, peripheral artery disease, and neurological disorders. They serve end users such as hospitals, ambulatory surgical centers, and catheterization laboratories.
The balloon introducer system market consists of sales of balloon introducer sheaths, balloon dilators, hemostatic valves, and guiding catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Balloon Introducer System Market Characteristics
3. Balloon Introducer System Market Supply Chain Analysis
4. Global Balloon Introducer System Market Trends and Strategies
5. Balloon Introducer System Market Analysis of End Use Industries
7. Global Balloon Introducer System Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Balloon Introducer System Total Addressable Market (TAM) Analysis for the Market
9. Balloon Introducer System Market Segmentation
10. Balloon Introducer System Market Regional and Country Analysis
11. Asia-Pacific Balloon Introducer System Market
12. China Balloon Introducer System Market
13. India Balloon Introducer System Market
14. Japan Balloon Introducer System Market
15. Australia Balloon Introducer System Market
16. Indonesia Balloon Introducer System Market
17. South Korea Balloon Introducer System Market
18. Taiwan Balloon Introducer System Market
19. South East Asia Balloon Introducer System Market
20. Western Europe Balloon Introducer System Market
21. UK Balloon Introducer System Market
22. Germany Balloon Introducer System Market
23. France Balloon Introducer System Market
24. Italy Balloon Introducer System Market
25. Spain Balloon Introducer System Market
26. Eastern Europe Balloon Introducer System Market
27. Russia Balloon Introducer System Market
28. North America Balloon Introducer System Market
29. USA Balloon Introducer System Market
30. Canada Balloon Introducer System Market
31. South America Balloon Introducer System Market
32. Brazil Balloon Introducer System Market
33. Middle East Balloon Introducer System Market
34. Africa Balloon Introducer System Market
36. Balloon Introducer System Market Competitive Landscape and Company Profiles
37. Balloon Introducer System Market Other Major and Innovative Companies
40. Balloon Introducer System Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Balloon Introducer System Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses balloon introducer system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for balloon introducer system? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The balloon introducer system market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Normal Balloon; Cutting And Scoring Balloon; Drug-Coated Balloon; Stent Graft Balloon Introducer2) By Technology: Rapid Exchange; Over The Wire; Fixed Wire Balloon Catheter
3) By Application: Coronary Artery Diseases; Peripheral Artery Diseases; Neurovascular Diseases
4) By End User: Hospitals; Ambulatory Surgical Centers; Catheterization Laboratories
Subsegments:
1) By Normal Balloon: Standard Balloon Introducers; Specialty Balloon Introducers2) By Cutting And Scoring Balloon: Cutting Balloon Introducers; Scoring Balloon Introducers
3) By Drug-Coated Balloon: Paclitaxel-Coated Balloons; Sirolimus-Coated Balloons
4) By Stent Graft Balloon Introducer: Stent Graft Delivery Systems; Balloon Expandable Stent Graft Introducers
Companies Mentioned: Cardinal Health Inc.; Johnson & Johnson; Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; B. Braun Melsungen AG; Terumo Corporation; Nipro Corporation; Cook Medical Inc.; Teleflex Incorporated; BIOTRONIK SE & Co. KG; Merit Medical Systems Inc.; MicroPort Scientific Corporation; Blue Sail Medical Co. Ltd.; Asahi Intecc Co. Ltd.; Japan Lifeline Co. Ltd.; AngioDynamics Inc.; OrbusNeich Medical; Biosensors International Group Ltd.; Alvimedica Medical Technologies; Hexacath; Cardionovum GmbH; Concept Medical Inc; Endocor GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Balloon Introducer System market report include:- Cardinal Health Inc.
- Johnson & Johnson
- Abbott Laboratories
- Medtronic plc
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Terumo Corporation
- Nipro Corporation
- Cook Medical Inc.
- Teleflex Incorporated
- BIOTRONIK SE & Co. KG
- Merit Medical Systems Inc.
- MicroPort Scientific Corporation
- Blue Sail Medical Co. Ltd.
- Asahi Intecc Co. Ltd.
- Japan Lifeline Co. Ltd.
- AngioDynamics Inc.
- OrbusNeich Medical
- Biosensors International Group Ltd.
- Alvimedica Medical Technologies
- Hexacath
- Cardionovum GmbH
- Concept Medical Inc
- Endocor GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.6 Billion |
| Forecasted Market Value ( USD | $ 5.23 Billion |
| Compound Annual Growth Rate | 9.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
